跳至主要内容
临床试验/CTRI/2025/02/081212
CTRI/2025/02/081212尚未招募2/3 期

Evaluation of Neurotransmitters during Vamana Karma with Madanphala yoga - An Exploratory study

Dr Jyoti Lakhlan1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
SERUM SEROTONIN LEVEL

研究概览

简要总结

Vamana karma is considered as the pradhana karma indicated for purification of upper part of body by inducing therapeutic vomiting. Amashaya and ura pradesh are the sthanas for kapha1. As per general principle of ayurveda, vitiated doshas should be expelled out through nearest route i.e. by oral route for kapha dosha.

Many Vamaka Dravyas are mentioned in bhritrayees, among them madanphala (Randia dometorum) is considered as the best vamaka dravya (emetic drug) because of its ‘anapayikatwa guna’ means having very less complications and  is safer to use.

Neurotransmitter are the mediators or chemical messengers which impact the induction of Vamana. This study is to create an evidence regarding changes in neurotransmitter level with respect to vamaka dravyas . In ayurveda principles, vamana is explained in terms of utklesh lakshana such as sweda pradhurbhava, lomharsh, kukshi adhyamana, hrullassa And samyak shudhhi lakshanas such as langiki, vaigiki, antiki and mainki. It is believed that neurotransmitters may play a major role in induction of vamana karma so to create an evidence this study has been initiated to visualize and create the data of impact of neurotransmitter on vamana karma with respect to usage of madanphala yoga which may guide in future.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Apparently healthy individual undergoing for vasantika vamana Patient aged between 18 to 40 years.
  • Patients who are willing to give blood samples.

排除标准

  • Patients contraindicated for vamana karma.
  • K/C/O of Hypertension, Diabetes Mellitus and other co morbidities Pregnant and lactating women.
  • Any severe illness.
  • Patients who are not willing to give blood samples.
  • Patient with lactose intolerance.

结局指标

主要结局

SERUM SEROTONIN LEVEL

时间窗: Day 0 at 7 AM 1 day before medicine administration | Day 1 at 7 AM before medicine administration | DAY 1 25 minutes after the medicine administration | DAY 1 50 minutes after the medicine administration

SERUM SUBSTANCE P LEVEL

时间窗: Day 0 at 7 AM 1 day before medicine administration | Day 1 at 7 AM before medicine administration | DAY 1 25 minutes after the medicine administration | DAY 1 50 minutes after the medicine administration

SERUM ACETYLCHOLINE LEVEL

时间窗: Day 0 at 7 AM 1 day before medicine administration | Day 1 at 7 AM before medicine administration | DAY 1 25 minutes after the medicine administration | DAY 1 50 minutes after the medicine administration

次要结局

  • Understand the sequence of events in Vamana Karma (Therapeutic Emesis) such as Kaphutkleshan (Vitiated dosha) , Vamana (Emetic) Drug Action, Vamanopaga (Emetic drugs) Drug Action with respect to Neurotransmitters(Kaphutkleshan (Vitiated dosha) on day 0 & day 1 ,Action of Vamana Drug (Emetic) & Vamanopaga (Emetic drugs) Drug on day 1)

研究者

发起方
Dr Jyoti Lakhlan
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Jyoti Lakhlan

KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Medical Research Centre

研究点 (1)

Loading locations...

相似试验